• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

    31.92 +0.24 (+0.76%)
    Streaming Delayed Price Updated: 12:12 PM EDT, Jul 23, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Hims & Hers Health, Inc. Class A Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    16 17 Next >
    News headline image
    Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company
    From Hims & Hers
    Via Business Wire
    News headline image
    Lowey Dannenberg, P.C. Investigates Hims & Hers Health, Inc. for Alleged Tracking of User Data
    From Lowey Dannenberg, P.C.
    Via GlobeNewswire
    News headline image
    Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026
    From Hims & Hers
    Via Business Wire
    News headline image
    Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims
    From Hims & Hers
    Via Business Wire
    News headline image
    Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World’s Largest Consumer Health Platform
    From Hims & Hers
    Via Business Wire
    News headline image
    Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners
    From Hims & Hers
    Via Business Wire
    News headline image
    Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets
    EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:MMA),(NYSE:NVO),(NYSE:HIMS),(NYSE:LLY) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Topics Government
    News headline image
    Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide
    From Hims & Hers
    Via Business Wire
    News headline image
    Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets
    Analysts project billions in future market value as biotech innovation and consumer demand continue driving the next wave of health performance products 
    From MarketNewsUpdates.com
    Via GlobeNewswire
    News headline image
    Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment
    From Hims & Hers
    Via Business Wire
    News headline image
    Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment
    From Hims & Hers
    Via Business Wire
    News headline image
    Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
    EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:PFE),(NYSE:NVO),(NYSE:HIMS),(NYSE:LLY) EQNX::TICKER_END 
    Via FinancialNewsMedia
    News headline image
    Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
    Next-generation wellness platforms targeting longevity, metabolism, and performance continue gaining momentum in one of healthcare’s fastest-growing sectors 
    From MarketNewsUpdates.com
    Via GlobeNewswire
    News headline image
    Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results
    From Hims & Hers
    Via Business Wire
    News headline image
    Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors
    From Hims & Hers
    Via Business Wire
    News headline image
    Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026
    From Hims & Hers
    Via Business Wire
    News headline image
    Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Novo Nordisk’s FDA-Approved GLP-1s Now Available With Hims & Hers
    From Hims & Hers
    Via Business Wire
    News headline image
    HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Hims & Hers Names Kathryn Beiser as Chief Communications Officer
    From Hims & Hers
    Via Business Wire
    News headline image
    Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers
    From Hims & Hers
    Via Business Wire
    News headline image
    ENDRA Life Sciences (NASDAQ: NDRA): The GLP-1 Healthcare Boom Offering Tremendous Opportunity Watch HIMS, ANTX, ATAI, PURR Now!
    Via AB Newswire
    News headline image
    Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    Hims & Hers Announces Strategic Shift for US Weight Loss Business
    From Hims & Hers
    Via Business Wire
    News headline image
    Glancy Prongay Wolke & Rotter LLP Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors
    From Glancy Prongay Wolke & Rotter LLP
    Via Business Wire
    News headline image
    Law Offices of Howard G. Smith Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    News headline image
    The Law Offices of Frank R. Cruz Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    News headline image
    Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
    From Hims & Hers
    Via Business Wire
    News headline image
    Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform
    From Hims & Hers
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    16 17 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.